1-4 of 4
Katherine L. Ruffner, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ALX148 Enhances the Depth and Durability of Response to Multiple AML Therapies

Amy Chen, Ons Harrabi, Abraham P Fong, MDPhD, Katherine L. Ruffner, MD, Alison J. Forgie, PhD, Janet Sim, PhD, Sophia S Randolph, MDPhD, Hong Wan, PhD, Jaume Pons, PhD, Tracy C Kuo, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 15–16.
https://doi.org/10.1182/blood-2020-137112
Published: 2020
Journal Articles

Brentuximab Vedotin Plus Doxorubicin, Vinblastine, Dacarbazine (A+AVD) As Frontline Therapy Demonstrates Superior Modified Progression-Free Survival Versus ABVD in Patients with Previously Untreated Stage III or IV Hodgkin Lymphoma (HL): The Phase 3 Echelon-1 Study

Joseph M Connors, MD, Wojciech Jurczak, PhDMD, David J. Straus, MD, Stephen M Ansell, MD PhD, Won Seog Kim, MD, Ph. D., Andrea Gallamini, MD, Anas Younes, MD, Sergei Alekseev, PhD, Arpad Illes, MD, Marco Picardi, Ewa Lech-Maranda, MDPhD, Yasuhiro Oki, MD, Tatyana A Feldman, MD, Piotr Smolewski, MD PhD, Kerry J Savage, BSc, MD MSc, Nancy L. Bartlett, MD, Jan Walewski, MD PhD, Robert W. Chen, MD, Rod Ramchandren, MD, Pier Luigi Zinzani, MD, David Cunningham, MD FRCP, Dae Seog Heo, MD, Andras Rosta, MD, Neil Josephson, MD, Katherine L. Ruffner, MD, Jessica Sachs, Rachael Liu, PhD, Hina Jolin, Pharm D, Dirk Huebner, MD, John A. Radford, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 6.
https://doi.org/10.1182/blood.V130.Suppl_1.6.6
Published: 2017
Journal Articles

A Phase 2, Double-Blind, Placebo-Controlled Trial of Rituximab + Galiximab Vs Rituximab + Placebo In Advanced Follicular Non-Hodgkin's Lymphoma (NHL)

Isabelle Bence-Bruckler, MD, FRCPC, David Macdonald, MD, FRCPC, Patrick J Stiff, MD, Byron McKinney, MS, Katherine L. Ruffner, MD, Lynn Wilson, Margaret Whiteley, BSc, Brad Kahl, MD
Journal: Blood
Blood (2010) 116 (21): 428.
https://doi.org/10.1182/blood.V116.21.428.428
Published: 2010
Journal Articles

Nucleated Cell (NC) Dose of Autologous (Auto) Marrow Graft Is Not Predictive of Engraftment after Auto-Bone Marrow Transplant (auto-BMT) Following Failed Peripheral Blood Stem Cell (PBSC) Mobilization.

Stephen A. Strickland, MD, Heidi Chen, PhD, Carole Hunt, RN, Wichai Chinratanalab, MD, Brian Engelhardt, MD, Stacey A. Goodman, MD, John P. Greer, MD, Adetola A. Kassim, MD, David Morgan, MD, Katherine L. Ruffner, MD, Friedrich Schuening, MD, Madan Jagasia, MBBS, MS
Journal: Blood
Blood (2006) 108 (11): 5454.
https://doi.org/10.1182/blood.V108.11.5454.5454
Published: 2006